Alamar Biosciences, Inc. · 1 day ago
Scientist I – Technology Access Program
Alamar Biosciences is dedicated to enabling scientific discoveries that benefit patients through innovative protein biomarker measurement. They are seeking a highly motivated Scientist to join their Technology Access team, where the successful candidate will design and execute NULISA immunoassay projects while collaborating with various teams to ensure timely completion of deliverables.
BiotechnologyHealth CareMedical
Responsibilities
Design, conduct, and analyze single-plex NULISA immunoassay experiments to assess various biomarkers across diverse biological matrices
Design and optimize assay parameters including sensitivity, specificity, detectability, and precision to execute and deliver NULISA immunoassay projects
Troubleshoot technical challenges via root-cause analysis and implement corrective strategies
Collaborate closely with cross-functional teams and external stakeholders to ensure the timely and accurate completion of deliverables
Qualification
Required
Ph.D. in Biochemistry, Molecular Biology, or a related discipline with 0–3 years of relevant industry experience; M.S. with 2–5 years of experience will also be considered
Hands-on experience in executing and optimizing immunoassays such as ELISA
Familiarity with molecular biology methods (e.g., qPCR, ddPCR)
Strong problem-solving and analytical skills with attention to detail in experimental execution
Ability to manage time effectively, work collaboratively, and adapt in a fast-paced environment
Strong communication skills, including data presentation and technical documentation
Preferred
Experience with high-sensitivity platforms (Simoa, MSD, or Luminex) is a plus but not required
Knowledge of biomarker research, assay validation, or clinical sample testing is desirable
Benefits
Bonus
Equity
Benefits
Company
Alamar Biosciences, Inc.
Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels.
H1B Sponsorship
Alamar Biosciences, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (6)
2023 (4)
2022 (3)
2021 (3)
Funding
Current Stage
Growth StageTotal Funding
$232MKey Investors
Alzheimer's Drug Discovery FoundationSands Capital VenturesSherpa Healthcare Partners
2025-01-08Grant· $10M
2024-02-26Series C· $128M
2021-09-08Series B· $80M
Recent News
Precedence Research
2025-11-10
Precedence Research
2025-10-24
Company data provided by crunchbase